Dillard’s (DDS) Form 144: Proposed sale of 750 shares, $442,024.80
Dillard’s (DDS): Notice of proposed insider sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dillard’s (DDS): Notice of proposed insider sale. A holder filed a Form 144 to sell up to 750 shares of Dillard’s common stock. The filing lists an aggregate market value of $442,024.80 and an approximate sale date of October 16, 2025. The shares are slated to be sold on the NYSE through Raymond James & Associates.
The shares to be sold were acquired via stock awards from the issuer on three dates: 400 shares on May 20, 2024, 100 shares on May 19, 2023, and 250 shares on May 22, 2017, with cash noted as the form of payment at acquisition.
The signer represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Dillard’s (DDS) disclose in this Form 144?
Does the Form 144 include a representation about undisclosed information?
AI-generated analysis. How Rhea-AI works. Not financial advice.